Clinical trial

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for…

NCT00334984 · Children's Oncology Group, Other · Withdrawn

Key facts

NCT number NCT00334984
Title Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
Official title Prevention of Mucositis in Children With AES-14 (IND#36978), a Glutamine Based Oral Care Regimen, for Patients Diagnosed With Solid Tumors: A Randomized Placebo-Controlled Clinical Study
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Withdrawn
Study type Interventional
Conditions Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma
Intervention type Drug, Procedure
Interventions glutamine, chemoprotection, management of therapy complications, therapeutic nutritional supplementation
Enrollment 0
Start date Jan 1, 2007
First posted Jun 8, 2006
Last update posted Jul 11, 2013

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies